Toshiharu Yamaguchi
Overview
Explore the profile of Toshiharu Yamaguchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
232
Citations
6966
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Updated Review of Proximal Gastrectomy for Gastric Cancer or Cancer of the Gastroesophageal Junction
Irino T, Ohashi M, Hayami M, Makuuchi R, Ri M, Sano T, et al.
J Gastric Cancer
. 2025 Jan;
25(1):228-246.
PMID: 39822177
Proximal gastrectomy (PG) has reemerged as a viable surgical option for managing proximal gastric cancer and gastroesophageal junction cancer, particularly for early-stage tumors, offering potential advantages over total gastrectomy (TG)....
2.
Suenaga M, Zhang W, Mashima T, Schirripa M, Cao S, Okazaki S, et al.
Cancer Genomics Proteomics
. 2021 Apr;
18(3):317-324.
PMID: 33893084
Background: Genetic variants in the CCL5/CCR5 pathway have been shown to predict regorafenib efficacy in patients with metastatic colorectal cancer (mCRC). This study investigated the biological role of CCL4 and...
3.
Suenaga M, Schirripa M, Cao S, Zhang W, Cremolini C, Lonardi S, et al.
Pharmacogenomics J
. 2021 Feb;
21(3):285-295.
PMID: 33542444
Colorectal cancer (CRC) can be classified into subtypes based on gene expression signatures. Patients with stage III enterocyte subtype of the CRC Assigner classifier have been shown to benefit from...
4.
Miyamoto Y, Schirripa M, Suenaga M, Cao S, Zhang W, Okazaki S, et al.
PLoS One
. 2020 Sep;
15(9):e0239439.
PMID: 32970737
Activin/myostatin signaling has a critical role not only in cachexia but also in tumor angiogenesis. Cachexia is a frequent complication among patients with advanced cancer and heavily pretreated patients. We...
5.
Suenaga M, Cao S, Zhang W, Matsusaka S, Okazaki S, Berger M, et al.
Pharmacogenet Genomics
. 2020 Aug;
31(1):10-16.
PMID: 32732498
Objectives: The enterocyte subtype of colorectal cancer (CRC) responds favorably to oxaliplatin-based adjuvant treatment for stage III CRC. We examined the clinical significance of single-nucleotide polymorphisms (SNPs) in enterocyte-related genes...
6.
Kumagai K, Hiki N, Nunobe S, Jiang X, Makuuchi R, Ida S, et al.
Surg Endosc
. 2020 Jul;
35(4):1843.
PMID: 32638122
No abstract available.
7.
Kumagai K, Hiki N, Nunobe S, Jiang X, Makuuchi R, Ida S, et al.
Surg Endosc
. 2020 May;
35(4):1834-1842.
PMID: 32356111
Background: Although laparoscopic gastrectomy (LG) is a widely accepted treatment for gastric cancer, conversion to laparotomy is sometimes required. The current study aimed to review the time trends of intraoperative...
8.
Ishida H, Yamaguchi T, Tanakaya K, Akagi K, Inoue Y, Kumamoto K, et al.
J Anus Rectum Colon
. 2019 Nov;
2(Suppl I):S1-S51.
PMID: 31773066
Hereditary colorectal cancer accounts for less than 5% of all colorectal cancer cases. Some of the unique characteristics that are commonly encountered in cases of hereditary colorectal cancer include early...
9.
Tsujiura M, Hiki N, Ohashi M, Nunobe S, Kumagai K, Ida S, et al.
Gastric Cancer
. 2019 Mar;
22(6):1247-1255.
PMID: 30888536
Background: Pylorus-preserving gastrectomy is an alternative to distal gastrectomy for early gastric cancer, and is expected to have postoperative advantages including maintenance of body weight. Overweight/obesity is a risk factor...
10.
Suenaga M, Cao S, Zhang W, Yang D, Ning Y, Okazaki S, et al.
Int J Cancer
. 2018 Nov;
144(10):2567-2577.
PMID: 30411783
Early VEGF-A reduction (EVR) by targeting abundant VEGF-A is a potential predictive marker of bevacizumab (BEV). The CCL5/CCR5 axis modulates VEGF-A production via endothelial progenitor cells migration. We tested whether...